Why the study?
What are the updated AHA recommendations for the diagnosis and treatment of GAS pharyngitis and the prevention of rheumatic fever?
What are the updated AHA recommendations for the diagnosis and treatment of GAS pharyngitis and the prevention of rheumatic fever?
Answers are grounded in this paper and cite their sources.
This updated AHA statement provides evidence-based recommendations for diagnosing and treating GAS pharyngitis to prevent initial and recurrent attacks of rheumatic fever.
Primary prevention of acute rheumatic fever is accomplished by proper identification and adequate antibiotic treatment of group A beta-hemolytic streptococcal (GAS) tonsillopharyngitis. Diagnosis of GAS pharyngitis is best accomplished by combining clinical judgment with diagnostic test results, the criterion standard of which is the throat culture. Penicillin (either oral penicillin V or injectable benzathine penicillin) is the treatment of choice, because it is cost-effective, has a narrow spectrum of activity, and has long-standing proven efficacy, and GAS resistant to penicillin have not been documented. For penicillin-allergic individuals, acceptable alternatives include a narrow-spectrum oral cephalosporin, oral clindamycin, or various oral macrolides or azalides. The individual who has had an attack of rheumatic fever is at very high risk of developing recurrences after subsequent GAS pharyngitis and needs continuous antimicrobial prophylaxis to prevent such recurrences (secondary prevention). The recommended duration of prophylaxis depends on the number of previous attacks, the time elapsed since the last attack, the risk of exposure to GAS infections, the age of the patient, and the presence or absence of cardiac involvement. Penicillin is again the agent of choice for secondary prophylaxis, but sulfadiazine or a macrolide or azalide are acceptable alternatives in penicillin-allergic individuals. This report updates the 1995 statement by the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee. It includes new recommendations for the diagnosis and treatment of GAS pharyngitis, as well as for the secondary prevention of rheumatic fever, and classifies the strength of the recommendations and level of evidence supporting them.
No takes yet. Share an insight, caveat, or question.
Gerber et al. (2009) conducted a review in Acute rheumatic fever and group A beta-hemolytic streptococcal (GAS) tonsillopharyngitis. Penicillin was evaluated. Penicillin remains the treatment of choice for both primary and secondary prevention of acute rheumatic fever and group A streptococcal pharyngitis.
Synapse has enriched 10 related papers. Consider them for comparative context: